(Q41994529)

English

Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males

scientific article published on May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 October 2017

Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males (English)

1 reference

Europe PubMed Central

PMC publication ID

15 October 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

activated carbon

1 reference

based on heuristic

inferred from title

activated charcoal

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

H Stass

1

1 reference

Europe PubMed Central

PMC publication ID

15 October 2017

D Kubitza

2

1 reference

Europe PubMed Central

PMC publication ID

15 October 2017

J-G Möller

3

1 reference

Europe PubMed Central

PMC publication ID

15 October 2017

H Delesen

4

1 reference

Europe PubMed Central

PMC publication ID

15 October 2017

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

PMC publication ID

15 October 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

15 October 2017

59

1 reference

Europe PubMed Central

PMC publication ID

15 October 2017

5

1 reference

Europe PubMed Central

PMC publication ID

15 October 2017

536-541

1 reference

Europe PubMed Central

PMC publication ID

15 October 2017

Pharmacokinetics of moxifloxacin, a novel 8-methoxy-quinolone, in patients with renal dysfunction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884843

5 June 2018

Effect of activated charcoal alone or given after gastric lavage in reducing the absorption of diazepam, ibuprofen and citalopram

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884843

5 June 2018

Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884843

5 June 2018

Intestinal elimination of sparfloxacin, fleroxacin, and ciprofloxacin in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884843

5 June 2018

Do gastric contents modify antidotal efficacy of oral activated charcoal?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884843

5 June 2018

Effect of oral activated charcoal on tobramycin clearance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884843

5 June 2018

Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884843

5 June 2018

Effects of orally administered activated charcoal on ciprofloxacin pharmacokinetics in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884843

5 June 2018

Activated charcoal, emesis, and gastric lavage in aspirin overdose

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884843

5 June 2018

https://pubmed.ncbi.nlm.nih.gov/15842551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884843

18 August 2018

Trans-epithelial intestinal elimination of moxifloxacin in rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of ethanol and pH on the adsorption of drugs to activated charcoal: studies in vitro and in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of gastric pH on antidotal efficacy of activated charcoal in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of absorbents on permeation of norfloxacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastrointestinal secretion of ciprofloxacin. Evaluation of the charcoal model for investigations in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transintestinal elimination of ciprofloxacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of BAY 12-8039, a new 8-methoxyquinolone, in human body fluids by high-performance liquid chromatography with fluorescence detection using on-column focusing

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of activated charcoal versus gastric lavage half an hour after ingestion of moclobemide, temazepam, and verapamil

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.2005.02357.X

1 reference

Europe PubMed Central

PMC publication ID

15 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41994529&oldid=2144545452"